BRPI0516574A - análogos do polipeptìdeo-6 da famìlia amilina (afp-6) e métodos para preparar e usar os mesmos - Google Patents

análogos do polipeptìdeo-6 da famìlia amilina (afp-6) e métodos para preparar e usar os mesmos

Info

Publication number
BRPI0516574A
BRPI0516574A BRPI0516574-1A BRPI0516574A BRPI0516574A BR PI0516574 A BRPI0516574 A BR PI0516574A BR PI0516574 A BRPI0516574 A BR PI0516574A BR PI0516574 A BRPI0516574 A BR PI0516574A
Authority
BR
Brazil
Prior art keywords
afp
analogs
methods
preparing
family polypeptide
Prior art date
Application number
BRPI0516574-1A
Other languages
English (en)
Inventor
Mary Erickson
Ved Srivastava
Sarah Mcquaid
Andrew Young
Richard Pittner
Soumitra Ghosh
Original Assignee
Amylin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc
Publication of BRPI0516574A publication Critical patent/BRPI0516574A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

ANáLOGOS DO POLIPEPTìDEO-6 DA FAMìLIA AMILINA (AFP-6) E MéTODOS PARA PREPARAR E USAR OS MESMOS. A presente invenção se refere a análogos do Polipeptídeo-6 da Família Amílina (AFP-6), os quais incluem derivados e fragmentos, ácidos nucléicos relacionados, constructos de expressão, células hospedeiras, e processos para produção recombinante dos análogos de AFP-6. Os análogos de AFP-6 da invenção incluem uma ou mais modificações da seqüência de aminoácidos. Além disso, são revelados métodos e composições para tratar e prevenir condições tais como distúrbios metabólicos e cardiovasculares, por exemplo, obesidade, diabetes, síndrome metabólica, isquemia do miocárdio, e aumento do risco cardiovascular.
BRPI0516574-1A 2004-10-08 2005-10-11 análogos do polipeptìdeo-6 da famìlia amilina (afp-6) e métodos para preparar e usar os mesmos BRPI0516574A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61746804P 2004-10-08 2004-10-08
PCT/US2005/036456 WO2006042242A2 (en) 2004-10-08 2005-10-11 Amylin family polypeptide- 6 (afp- 6) analogs and methods of making and using them

Publications (1)

Publication Number Publication Date
BRPI0516574A true BRPI0516574A (pt) 2008-09-16

Family

ID=36148999

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0516574-1A BRPI0516574A (pt) 2004-10-08 2005-10-11 análogos do polipeptìdeo-6 da famìlia amilina (afp-6) e métodos para preparar e usar os mesmos

Country Status (8)

Country Link
US (1) US7928060B2 (pt)
EP (3) EP1797121A2 (pt)
JP (1) JP2008515443A (pt)
CN (1) CN101035806A (pt)
AU (1) AU2005295043A1 (pt)
BR (1) BRPI0516574A (pt)
CA (1) CA2580991A1 (pt)
WO (1) WO2006042242A2 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7671023B2 (en) 2005-03-31 2010-03-02 Amylin Pharmaceuticals, Inc. Amylin agonist for treating depression, anxiety disorder and schizophrenia
US20090181890A1 (en) * 2006-03-31 2009-07-16 Amylin Pharmaceuticals , Inc. Amylin and Amylin Agonists for Treating Psychiatric Diseases and Disorders
US8309522B2 (en) 2007-02-05 2012-11-13 Amylin Pharmaceuticals, Llc Neuromedin and FN-38 peptides for treating psychiatric diseases
WO2009046852A1 (en) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Therapeutic uses of intermedin 47 and 53 peptides
WO2009040047A2 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Therapeutic uses of ghrelin and combinations with stresscopin
US8858915B2 (en) 2007-11-26 2014-10-14 Japan Science & Technology Agency Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome
GB201001333D0 (en) 2010-01-27 2010-03-17 Imp Innovations Ltd Novel compounds and their effects on feeding behaviour
AU2012240144B2 (en) 2011-04-07 2017-05-25 The Board Of Trustees Of The Leland Stanford Junior University Long-acting peptide analogs
EP3109256A1 (en) * 2012-04-19 2016-12-28 Novo Nordisk A/S Polypeptides
EP3400237A4 (en) 2016-01-04 2020-03-04 Adepthera LLC Peptide analogs
US11701409B2 (en) 2016-02-09 2023-07-18 Adepthera Llc Dosing and use of long-acting CLR/ramp agonists
CN106749612B (zh) * 2016-10-14 2020-06-16 四川大学华西医院 中介素相关多肽及其在脓毒症预防和治疗中的用途
US20190153059A1 (en) 2017-06-30 2019-05-23 Adepthera Llc Peptide analogs
US11274158B2 (en) * 2018-01-30 2022-03-15 Flagship Pioneering Innovations V, Inc. Methods and compositions for treating inflammatory or autoimmune diseases or conditions using calcitonin receptor activators
WO2024164776A1 (zh) * 2023-02-10 2024-08-15 杭州先为达生物科技股份有限公司 多肽及其衍生物、组合物及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
NZ229098A (en) 1988-05-13 1992-10-28 Amgen Inc (bg-csf) bovine granulocyte colony stimulating factor, recombinant methods and pharmaceuticals
US5264372A (en) 1991-03-15 1993-11-23 Amylin Pharmaceuticals, Inc. Receptor-based screening methods for amylin agonists and antagonists
HU222249B1 (hu) 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
US5686511A (en) 1996-06-28 1997-11-11 The Valspar Corporation Esterifying epoxy resin with carboxyl polymer and quenching
AU749914B2 (en) 1997-08-08 2002-07-04 Amylin Pharmaceuticals, Inc. Novel exendin agonist compounds
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
EP1066314B1 (en) 1997-11-14 2007-12-26 Amylin Pharmaceuticals, Inc. Novel exendin agonist compounds
DK1032587T4 (da) 1997-11-14 2013-04-08 Amylin Pharmaceuticals Llc Hidtil ukendte exendinagonist-forbindelser
US6630169B1 (en) 1999-03-31 2003-10-07 Nektar Therapeutics Particulate delivery systems and methods of use
CN100350968C (zh) 2001-09-24 2007-11-28 皇家创新有限公司 饮食行为的改进
JP4733922B2 (ja) 2002-01-10 2011-07-27 インペリアル・イノベ−ションズ・リミテッド 摂食行動の修正
WO2004048547A2 (en) 2002-11-26 2004-06-10 The Board Of Trustees Of The Leland Stanford Junior University Intermedin and its uses
US8603969B2 (en) 2004-02-11 2013-12-10 Amylin Pharmaceuticals, Llc Pancreatic polypeptide family motifs and polypeptides comprising the same
CN1961000B (zh) 2004-02-11 2011-05-04 安米林药品公司 具有可选择特性的杂合多肽
US7399744B2 (en) 2004-03-04 2008-07-15 Amylin Pharmaceuticals, Inc. Methods for affecting body composition

Also Published As

Publication number Publication date
EP1797121A2 (en) 2007-06-20
EP2314615A3 (en) 2011-07-20
US7928060B2 (en) 2011-04-19
AU2005295043A1 (en) 2006-04-20
EP2314615A2 (en) 2011-04-27
CA2580991A1 (en) 2006-04-20
JP2008515443A (ja) 2008-05-15
CN101035806A (zh) 2007-09-12
EP2631244A1 (en) 2013-08-28
US20080207501A1 (en) 2008-08-28
WO2006042242A2 (en) 2006-04-20
WO2006042242A3 (en) 2007-04-26

Similar Documents

Publication Publication Date Title
BRPI0507623A (pt) peptìdeos da famìlia da amilina e métodos para prepará-los e empregá-los
BRPI0516574A (pt) análogos do polipeptìdeo-6 da famìlia amilina (afp-6) e métodos para preparar e usar os mesmos
BRPI1010880A2 (pt) polipeptídeos de hormônio de crescimento e métodos de fazer e usar os mesmos.
BRPI0611909A2 (pt) biossÍntese aperfeiÇoada de aminoÁcido e metabàlito
BR112012033699A2 (pt) polipeptídeo tendo atividade beta-glicosidase e seus usos
BR112012029588A2 (pt) materiais biológicas relacionados a her3.
BRPI0919932A8 (pt) Pirrolina-carbóxi-lisina gerada biossinteticamente, bem como processo para preparar método para derivatizar uma proteína
EA201200398A1 (ru) Полипептиды с оксидоредуктазной активностью и их применение
UY31875A (es) Novedosos genes involucrados en la biosíntesis
NO20092774L (no) HLA-A*1101-begrenset WT1-peptid og farmasoytisk preparat som omfatter dette
EA200800368A1 (ru) Гликозилированный il-7, получение и применение
WO2010041913A3 (ko) Grs 단백질 또는 이의 단편의 신규한 용도
EA201170878A1 (ru) Полипептиды с ксиланазной активностью
EP2470670A4 (en) COAGULATION FACTOR VII COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF
ES2353814T3 (es) Proteinas n-glicosiladas recombinantes de celulas procariotas.
BR112012006501A8 (pt) Polipeptídios e usos dos mesmos
BRPI0923346A2 (pt) Proteinas em super-helice antiparalela de cadeia simples
BR112012016320B8 (pt) Método para tratar material celulósico, polipeptídeo, molécula de ácido nucleico isolada, vetor de expressão recombinante, célula hospedeira, processos para produzir um polipeptídeo, e para obter uma preparação de enzima, preparação de enzima, e, uso do polipeptídeo ou da preparação de enzima
NO20092360L (no) Nye antiproliferasjonsantistoffer
BRPI0921096A8 (pt) Composições e métodos para inibir a expressão dos genes de fator vii
AR070058A1 (es) Enzima bacteriana asociada con la sintesis de ecuol
BR112012033714A2 (pt) polipeptídeo com atividade de acetil xilano esterase e seus usos.
MX2020005724A (es) Variantes de alfa-amilasa y polinucleotidos que codifican las mismas.
BR112023019874A2 (pt) Produção de bioconjugados de e. coli o18
BRPI0911634B8 (pt) processo para a preparação de 5-(2-amino-pirimidin-4-il)-2-aril-1h-pirrol-3-carboxamidas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.